Drug Resistance Updates Pharmacology
ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma
The publisher did not provide an abstract — full text is available via the link below.
Drug Resistance Updates Pharmacology
The publisher did not provide an abstract — full text is available via the link below.